Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in combination with bortezomib and dexamethasone in refractory multiple myeloma
NCT00555906Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2008
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of palbociclib in multiple myeloma (MM), sponsored by Pfizer. Started Jan 2008; status: completed.
02
Drugs
palbociclib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00555906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555906.